捷迈邦美 2025年度报告

FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGE ACT OF 1934For year ended December 31, 2025Commission file number 001-16407 ZIMMER BIOMET HOLDINGS, INC. (Exact name of registrant as specified in its charter) Securities registered pursuant to Section 12(b) of the Act: Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.Yes☒No☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.Yes☐No☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during thepreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of RegulationS-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).Yes☒No☐ Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerginggrowth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2of the Exchange Act. Large accelerated filer☒Non-accelerated filer☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisedfinancial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control overfinancial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its auditreport.☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflectthe correction of an error to previously issued financial statements.☐Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).Yes☐No☒The aggregate market value of shares held by non-affiliates was $18,023,763,265(based on the closing price of these shares on the New York Stock Exchange onJune 30, 2025 and assuming solely for the purpose of this calculation that all directors and executive officers of the registrant are “affiliates”). As of February 10,2026, 195,652,004 shares of the registrant’s $.01 par value common stock were outstanding. Documents Incorporated by Reference Document Portions of the Proxy Statement with respect to the 2026 Annual Meeting of Stockholders ZIMMER BIOMET HOLDINGS, INC.ANNUAL REPORTCautionary Note Regarding Forward-Looking Statements This Annual Report contains forward-looking statements within the meaning of federal securities laws, including, among others,statements regarding sales and earnings guidance and any statements about our expectations, plans, intentions, strategies orprospects. We generally use the words “may,” “will,” “can,” “expects,” “believes,” “anticipates,” “plans,” “estimates,” “projects,”“assumes,” “guides,” “targets,” “forecasts,” “sees,” “seeks,” “should,” “could,” “would,” “predicts,” “potential,” “strategy,”“future,” “opportunity,” “work toward,” “intends,” “guidance,” “confidence,” “position,” “design,” “strive,” “continue,” “lookforward to” and similar expressions to identify forward-looking statements. All statements other than statements of historical orcurrent fact are, or may be deemed to be, forward-looking statements. Such statements are based upon the current beliefs,expectations and assumptions of management and are subject to significant risks, uncertainties and changes in circumstances thatcould cause actual outcomes and results to differ materially from the forward-looking statements. These risks, uncertainties andchanges in circumstances include, but are not limited to: competition; pricing pressures; dependence on new product development,technological advances and innovation; changes in customer demand for our products and services caused by demographicchanges, obsolescence, development of different therapies or other fact